Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,696 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer

NCT00661778

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Palma de Mallorca, Balearic Islands, Spain
  • Cadiz, Spain
  • Castellon, Spain
  • Donostia / San Sebastian, Guipuzcoa, Spain
View all 14 locations
View Trial Details
Completed

Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC

NCT00499109

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Center for Cancer Care & Research/Watson Lakeland, Florida, United States
  • Leesburg Regional Medical Center Leesburg, Florida, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Johns Hopkins Sidney Kimmell Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)

NCT00148798

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Buenos Aires, Argentina
  • Research Site Córdoba, Argentina
  • Research Site Adelaide, Australia
  • Research Site Melbourne, Australia
View all 118 locations
View Trial Details
Completed

Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC

NCT00620971

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece
  • "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece
  • "Metaxa's" Anticancer Hospital of Piraeus,1st Dep of Medical Oncology Athens, Greece
  • 401 Military Hospital, Medical Oncology Unit Athens, Greece
View Trial Details
Completed

EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)

NCT00879866

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands
  • Department of Pulmonology, Academic Hosptial Maastricht Masstricht, Netherlands
  • Department of Medical Oncology (452), Radboud UMC Nijmegen Nijmegen, Netherlands
View Trial Details
Completed

Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

NCT00368927

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Lahey Hospital and Medical Center Burlington, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details

Related conditions